The extensive metabolic demands of pregnancy require specific physiological and
anatomical changes. These changes affect almost all organ systems, including the …

Key points Venous thromboembolism (VTE) in pregnancy remains a leading cause of direct
maternal mortality in the developed world and identifiable risk factors are increasing in …

BACKGROUND Bleeding is a potential complication after neuraxial and peripheral nerve
blocks. The risk is increased in patients on antiplatelet and anticoagulant drugs. This joint …

Background Pregnancy-related venous thromboembolism is a leading cause of maternal
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …

Venous thromboembolism (VTE), which may manifest as pulmonary embolism (PE) or deep
vein thrombosis (DVT), is a serious and potentially fatal condition. Treatment and prevention …

Venous thromboembolism is recognized as a leading cause of maternal death in the United
States. Thromboprophylaxis has been highlighted as a key preventive measure to reduce …

Pregnancy is associated with a hypercoagulable state. Women requiring anticoagulation
need careful attention throughout pregnancy and the post-partum period. The choice of …

Key Clinical Points Venous Thrombosis in Pregnancy Venous thromboembolism is a
leading cause of maternal mortality and morbidity in the developed world. The risk of deep …

Venous thromboembolism (VTE) is a major cause of maternal morbidity during pregnancy
and the postpartum period. However, because there is a lack of adequate study data …

Background Emerging safety and efficacy data for rivaroxaban suggest traditional therapy
and rivaroxaban are comparable in the morbidly obese. However, real‐world data that …